Skip to main content
logo
GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,670.00
+2,136.00 (400.00%)
Jul 22, 2026, 7:45 AM KST

GeneOne Life Science Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-48,936-51,851-48,537-77,768-38,150-15,888
Depreciation & Amortization
17,11618,19617,96112,7765,4244,650
Loss (Gain) From Sale of Assets
10.19-43.83-2.82-3.4-1.31106.64
Asset Writedown & Restructuring Costs
---32,309--
Loss (Gain) From Sale of Investments
0.39-4.25---
Provision & Write-off of Bad Debts
398.981572.7-845.521,293111.17
Other Operating Activities
11,88011,0108,4423,1713,579-2,084
Change in Accounts Receivable
3,2845,069407.864,835-2,84868.06
Change in Inventory
1,9762,005-2,096-207.63-4,256-2,415
Change in Accounts Payable
5,5373,45610,2403,801-10,00310,610
Change in Income Taxes
-19.62-----97.74
Change in Other Net Operating Assets
-4,399-4,416-1,987188.3320,850-194.83
Operating Cash Flow
-13,274-16,541-16,058-21,744-24,113-4,849
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-18.62-23.82-3,298-5,601-45,306-82,442
Sale of Property, Plant & Equipment
48.1848.182.1215.7-29.13
Sale (Purchase) of Intangibles
-20.5-35.25-69.14-51.59-101.81-75.24
Investment in Securities
-1,123-698470.7931,52953,000-57,000
Other Investing Activities
161.0343446-0-151.33-5,961
Investing Cash Flow
-1,448-769.89-2,84525,8928,055-146,398

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-30,8731,3523,792701.151,054
Long-Term Debt Issued
-6,2469,2246,27111,469-
Total Debt Issued
32,31037,11910,57610,06312,1711,054
Short-Term Debt Repaid
--16,879-506.85-2,100--150.86
Long-Term Debt Repaid
--3,836-2,700-18,712-5,537-1,639
Total Debt Repaid
-26,955-20,715-3,207-20,812-5,537-1,790
Net Debt Issued (Repaid)
5,35516,4047,369-10,7496,633-735.35
Issuance of Common Stock
9,0151,0003,5902,470382.44112,609
Other Financing Activities
44.4846.91-0-5.64-2.97-849.86
Financing Cash Flow
14,41417,45110,959-8,2857,013111,023

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.69-1.1813.81-13.29-3.42101.37
Miscellaneous Cash Flow Adjustments
-0-00-00
Net Cash Flow
-306.24138.54-7,931-4,150-9,049-40,122

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13,293-16,565-19,356-27,345-69,419-87,291
Free Cash Flow Growth
------
Free Cash Flow Margin
-107.50%-71.88%-54.19%-68.02%-142.49%-225.56%
Free Cash Flow Per Share
-733.06-1004.30-1218.29-1758.52-4479.48-5878.87
Levered Free Cash Flow
6,6853,4872,211-22,581-73,691-103,116
Unlevered Free Cash Flow
10,0306,7003,558-21,843-69,123-100,332

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
124.5454.2674.6682.1558.5-
Cash Income Tax Paid
--103.42-236.05104.9326.55189.71
Change in Working Capital
6,2565,9916,0718,6173,7438,255